Sign In
Buy AKTS
$28.70
+1.69 (+6.26%)
At Close: Jun 24, 2026
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
08:48pm, Thursday, 08'th Jan 2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to larg
